SARS-CoV-2(2) peptides(1) Hepatitis(1) Gene therapy(1) swine(1) inactivated(1) Cas13(1) Tolerability(1) problems(1) participant(1) System(1) approach(1) COVID-19(1) demonstrated(1) Vaccines(1) immune responses(1) CRISPR(1) Infectious diseases(1) rodent(1) hepatitis B(1) Proinflammatory response(1) Protein subunit(1) Cas9(1) individual(1) effector(1) knockout(1) mRNA-based vaccine(1) variety(1) robust(1) clinical trial(1)